Hanover, Germany

Thomas Dschietzig

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Relaxera Pharma Gmbh & Co. Kg I.g.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Dschietzig. Retrieved from https://idiyas.com/inventor/thomas-dschietzig-dmaltxvl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Thomas Dschietzig: Advancing Relaxin-2 Production

Introduction: Thomas Dschietzig is an accomplished inventor based in Hannover, Germany. He is recognized for his significant contribution to the field of biochemistry through his innovative patent related to human relaxin-2.

Latest Patents: Dschietzig holds a patent for a "Process for preparing human relaxin-2." This patent details a sophisticated method for producing human relaxin-2, which has important applications in medical research and therapeutic practices. The unique amino acid sequence associated with this protein demonstrates its potential in various clinical contexts.

Career Highlights: Thomas Dschietzig currently works at Relaxera Pharma GmbH & Co. KG. His role in this company underscores his commitment to advancing medical science, specifically through his work on relaxin-2, which may have implications in treating conditions related to fertility and pregnancy.

Collaborations: Throughout his career, Dschietzig has collaborated with esteemed colleagues, including Wolf-Georg Forssmann and Ludger Ständker. These partnerships have fostered an environment of innovation, enhancing the development of breakthroughs in pharmaceutical research.

Conclusion: Thomas Dschietzig's dedication to the field of biochemistry and his contributions through his patent for human relaxin-2 position him as a notable figure in the landscape of modern medical research. His work at Relaxera Pharma GmbH & Co. KG, along with collaborations with prominent scientists, highlights the impact of his innovations on the future of therapeutic interventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…